Search Results

Abnormal Tau, a Sign of Alzheimer’s Disease in the Brain, Is Present in Dying Nerve Cells in the Retina and Linked to Cognitive Decline, Study Finds

HSV-1 is associated with Alzheimer’s-associated transposable elements in infected, Alzheimer’s-affected brains, which may be reversed through available drugs.

Cleveland Clinic-led study strengthens the connection between changes in microglia and Alzheimer’s disease and identifies drugs that may stop or reverse these changes.

IU School of Medicine researchers have uncovered key mechanisms that may protect against cognitive decline in Alzheimer's disease.

Synthetic THC (Dronabinol) was well tolerated by patients without the adverse effects often seen with current Alzheimer’s agitation medications

Real-world evidence supports repurposing GLP-1 receptor agonists for Alzheimer’s prevention, with semaglutide showing significant benefits